Highlights Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

Market Closed - OTC Markets Other stock markets 10:56:18 2024-04-26 am EDT			5-day change	1st Jan Change
0.1105 ^USD	+8.33%		+2.31%	-57.71%

2021	RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	CI
2021	Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RafarmaPharmaceuticals, Inc. to Add Major Component to the Tashkent Pharma Park	21-12-17	CI
Rafarma Pharmaceuticals, Inc. to Expand Proton Therapy Centers	21-05-07	CI
Rafarma Pharmaceuticals, Inc. Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	21-01-29	CI
Vaccines Lab Sdn Bhd Enters Master Strategic Joint Venture Agreement with Rafarma Pharmaceuticals Inc	20-12-15	CI
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer	20-12-09	GL
Rafarma Pharmaceuticals, Inc. Signs a Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia	20-12-01	CI
Rafarma Pharmaceuticals : Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger	20-11-04	AQ
Auditing Firm L J Soldinger Associates Retained for Rafarma Biocogency Merger	20-11-04	GL
Rafarma Pharmaceuticals : Closes Biocogency Merger	20-10-19	AQ
Rafarma Closes Biocogency Merger	20-10-19	GL
R. & D. Biocogency Laboratories Inc. Ltd. completed the acquisition of an unknown majority stake in Rafarma Pharmaceuticals, Inc..	20-10-18	CI
Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects	20-08-25	GL
Rafarma Pharmaceuticals : Establishes Thailand Corporate Entity For Merger and Expansion Projects	20-08-25	AQ
Rafarma Establishes Thailand Corporate Entity for Merger and Expansion Projects	20-08-25	CI
R. & D. Biocogency Laboratories Inc. Ltd. agreed to acquire an unknown majority stake in Rafarma Pharmaceuticals, Inc..	20-08-03	CI
Rafarma Pharmaceuticals, Inc. Announces Finalization of the Agreement with Destination Marketing Group Co. Ltd	20-06-22	CI
Rafarma Pharmaceuticals, Inc. Announces Commencement of Tests for Its New Product Hempysleep	20-06-15	CI
Rafarma Pharmaceuticals, Inc. Agrees Terms to Open Its First Specialized Cannabis Spa in Europe	20-03-23	CI
Rafarma Pharmaceuticals Inc. Officially Begun Research Programs with Khon Kaen University in Thailand	20-02-24	CI
Rafarma Announces Cooperative Research Programs with the Faculty of Medicine, Khon Kaen University, Thailand	20-02-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Rafarma Pharmaceuticals, Inc.

Equities

RAFA

US75062C1009

Highlights

Filters